MCRB Archived Articles
Seres Therapeutics (NASDAQ:MCRB): Pioneering Live Biotherapeutics to Revolutionize Patient Outcomes
Published on March 15, 2025
Seres Therapeutics, Inc. (NASDAQ:MCRB): Commercializing VOWST and Advancing Promising Microbiome Therapeutic Pipeline
Published on September 24, 2024